Navigation Links
Advanced Life Sciences Announces Supplemental Efficacy Data from,First Pivotal Phase 3 Pneumonia Clinical Trial

. -- Modified intent-to-treat radiographic success rate -- cethromycin 88.3% (227/257) compared to Biaxin(R) 91.7% (232/253) [-8.8, +2.0] (p=0.2383). Based on the 91.7% clinical cure rate for Biaxin(R) being 90% or greater, a delta value of 10% or less on the lower bound and greater than zero on the upper bound [-8.8, +2.0] establishes non-inferiority. Under this analysis, the study met the endpoint of modified intent-to-treat radiographic success rate. Since p>0.05, there is not a statistically significant difference between cethromycin and Biaxin(R), which supports non-inferiority. -- Bacteriological cure rate -- cethromycin 89.1% (57/64) compared to Biaxin(R) 96.8% (61/63). The bacteriologically evaluable population for each arm of the trial was not powered to demonstrate statistical non-inferiority at a 95% confidence interval. -- Percent of bacteriologically evaluable patients -- approximately 28% of subjects in the per protocol population were bacteriologically evaluable. The Company believes that this percentage of bacteriologically evaluable patients is in-line with rates observed in precedent successful antibiotic drug approvals and will add to its overall bacteriologically evaluable patient database. -- Discontinuation rate -- from the modified intent-to-treat population, discontinuation rate due to adverse events was 1.6% for cethromycin and 2.8% for Biaxin(R). Total discontinuation rate (due to adverse events, clinical failure, exclusion criteria and withdrawal of consent) was 7.0% for cethromycin and 7.9% for Biaxin(R). Both cethromycin and Biaxin(R) were well tolerated with discontinuation rates similar to those observed in prior clinical trials.

Cethromycin was evaluated using a 300 mg once-daily dosing regimen compared to 250 mg twice-daily
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. BusinessWeek Article Highlights Promising Breakthrough Treatment for Advanced Coronary Artery Disease
3. BusinessWeek Article Highlights Promising Breakthrough Treatment for Advanced Coronary Artery Disease
4. Advanced Life Sciences to Host Conference Call to Discuss Data From Cethromycins First of Two Phase 3 Pneumonia Trials
5. Progenics and Wyeth Announce Positive Results from Three-Month Clinical-Extension Study of Subcutaneous Methylnaltrexone for the Treatment of Opioid-Induced Constipation in Patients with Advanced Illness
6. Advanced Cell Technology Develops First Human Embryonic Stem Cell Line without Destroying an Embryo
7. Neurologix Announces Publication of Landmark Gene Therapy Study Demonstrating Safety and Statistically Significant Improvement in Patients With Advanced Parkinsons Disease
8. Advanced Viral Research Corp. Announces Positive Preliminary Findings from Ongoing Phase II Dermatological Study
9. Clinical Data Reported on Vidaza in Hematologic Malignancies and Advanced Solid Tumors
10. Updated Study Results Reinforce Survival Benefit of Taxotere (Docetaxel) for Men with Advanced, Hormone-Resistant Prostate Cancer
11. GSKS Pazopanib Shows Positive Results in Patients with Advanced Renal Cell Carcinoma, Ovarian Cancer and Soft Tissue Sarcoma
Post Your Comments:
(Date:7/29/2015)... Surgical Company (NASDAQ: STAA ), a leading developer, manufacturer ... eye today reported financial results for the second quarter ended ... , Net Sales of $18.7 Million Down 7% from the ... Million from the Weakening Euro and Yen , ICL ... , APAC Sales Down 1% Including Korea - Up 16% ...
(Date:7/29/2015)... ALTO, Calif. , July 29, 2015 ... it has, through one of its European subsidiaries, agreed ... -based supplier of components and subsystems for X-ray imaging ... will pay approximately €50 million in cash for ... August. Claymount is one of the ...
(Date:7/29/2015)... 2015  Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA ... second quarter ended June 30, 2015. "We ... and Fanapt" said Mihael H. Polymeropoulos M.D., Vanda,s President ... cycle management of our products set the stage for ... Financial Highlights , Total net product sales ...
Breaking Medicine Technology:STAAR Surgical Reports Second Quarter 2015 Results 2STAAR Surgical Reports Second Quarter 2015 Results 3STAAR Surgical Reports Second Quarter 2015 Results 4STAAR Surgical Reports Second Quarter 2015 Results 5STAAR Surgical Reports Second Quarter 2015 Results 6STAAR Surgical Reports Second Quarter 2015 Results 7STAAR Surgical Reports Second Quarter 2015 Results 8STAAR Surgical Reports Second Quarter 2015 Results 9STAAR Surgical Reports Second Quarter 2015 Results 10STAAR Surgical Reports Second Quarter 2015 Results 11STAAR Surgical Reports Second Quarter 2015 Results 12STAAR Surgical Reports Second Quarter 2015 Results 13STAAR Surgical Reports Second Quarter 2015 Results 14STAAR Surgical Reports Second Quarter 2015 Results 15STAAR Surgical Reports Second Quarter 2015 Results 16STAAR Surgical Reports Second Quarter 2015 Results 17STAAR Surgical Reports Second Quarter 2015 Results 18STAAR Surgical Reports Second Quarter 2015 Results 19STAAR Surgical Reports Second Quarter 2015 Results 20STAAR Surgical Reports Second Quarter 2015 Results 21STAAR Surgical Reports Second Quarter 2015 Results 22STAAR Surgical Reports Second Quarter 2015 Results 23STAAR Surgical Reports Second Quarter 2015 Results 24Varian Medical Systems Acquiring Claymount to Expand Imaging Components Portfolio 2Varian Medical Systems Acquiring Claymount to Expand Imaging Components Portfolio 3Varian Medical Systems Acquiring Claymount to Expand Imaging Components Portfolio 4Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 2Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 3Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 4Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 5Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 6Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 7Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 8Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 9Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 10
... TetraLogic Pharmaceuticals , a biopharmaceutical company developing novel small ... the oral presentation of new data on its Smac ... Meeting and Exposition in San Diego. The study, conducted ... Center, demonstrated that TL32711 induces apoptosis in acute myeloid ...
... Dec. 10, 2011  A group of Penn Medicine researchers is ... they,re challenging the public to help. The MyHeartMap Challenge, a ... will send thousands of Philadelphians to the streets and to ... (AEDs) as they can. The contest is just a first ...
Cached Medicine Technology:TetraLogic Pharmaceuticals Announces Oral Presentation on Smac Mimetic TL32711 at American Society of Hematology (ASH) Annual Meeting 2Penn Medicine Contest Challenges Philadelphians to Help Save Lives With Their Cell Phones 2Penn Medicine Contest Challenges Philadelphians to Help Save Lives With Their Cell Phones 3Penn Medicine Contest Challenges Philadelphians to Help Save Lives With Their Cell Phones 4
(Date:7/29/2015)... ... July 29, 2015 , ... Potomac Pilates, an elite Washington, D.C. metro ... Rock the Reformer ® by Potomac Pilates. On Thursday, July 30, Potomac Pilates ... Reformer ® by Potomac Pilates will continue to offer the same classes and personal ...
(Date:7/29/2015)... ... July 29, 2015 , ... Ticket Down is a ... Brazil vs. USA . , The international soccer schedule of matches ... exponentially and now on September 8th, one of the world’s greatest teams, Brazil, will ...
(Date:7/29/2015)... ... , ... This year, the threat of flooding is higher in many areas ... water, mold is not far behind. Paul Davis, a leading provider of property restoration ... damage. Paul Davis is regularly called on to handle these types of emergencies, although ...
(Date:7/29/2015)... ... July 29, 2015 , ... San Fernando Valley ... Ultherapy. For a limited time only, patients can get the complete treatment process with ... patients who prefer a non-invasive treatment and have loose or sagging skin. , ...
(Date:7/29/2015)... Los Angeles, CA (PRWEB) , ... July 29, 2015 , ... We are privileged to ... at Keck Medicine of USC as the ninth best ophthalmology hospital in the nation for ... the top 10 American hospitals for ophthalmology. , “It is an honor to be ...
Breaking Medicine News(10 mins):Health News:Same Great Pilates Studio, New Brand - Rock the Reformer 2Health News:Cheap USA vs. Brazil Tickets at Gillette Stadium: Ticket Down Cuts Presale Ticket Prices for Brazil vs. USA Men's National Soccer Team (USMNT) at Gillette Stadium 2Health News:Cheap USA vs. Brazil Tickets at Gillette Stadium: Ticket Down Cuts Presale Ticket Prices for Brazil vs. USA Men's National Soccer Team (USMNT) at Gillette Stadium 3Health News:Paul Davis Offers Tips to Minimize Property Damage and Health Risks This Flood Season 2Health News:Paul Davis Offers Tips to Minimize Property Damage and Health Risks This Flood Season 3Health News:San Fernando Valley Dermatology Office, Castle Dermatology Institute, is Now Offering a Promotional Price on Ultherapy 2Health News:21 Years & Counting: The USC Eye Institute Ranks in the Top 10 Ophthalmology Hospitals in America 2Health News:21 Years & Counting: The USC Eye Institute Ranks in the Top 10 Ophthalmology Hospitals in America 3
... Media have less than three weeks to register ... Multidisciplinary Cancer Congress in Stockholm, 23-27 September 2011. ... European Multidisciplinary Cancer Congress will take place at ... www.stofair.se ) from Friday 23 September to Tuesday ...
... A genomic study of chronic blood cancer - a precursor ... diagnosis using only a blood test, avoiding the need for ... the Wellcome Trust Sanger Institute identified the SF3B1 gene as ... forms of blood cancer. Myelodysplasia is particularly prevalent among people ...
... MONDAY, Sept. 26 (HealthDay News) -- People with heart disease ... return to a normal rate after exercise, a new study ... with normal heart rate recovery live longer than those whose ... "There,s no medicine that can do that," study author ...
... University professor is leading research efforts to develop new ... a neurodegenerative disorder that affects nearly six million people ... diagnosed in the United States alone each year. ... rigid muscles, difficulty initiating movement, speech changes, postural instability ...
... The Autism Speaks Autism Treatment Network (ATN), has received ... as the Autism Intervention Research Network on Physical Health ... guidelines, tool kits for families and physicians, and clinician ... a jump start in developing the kinds of research ...
... released this week, challenges people to test their knowledge ... they learn about the complexities of the disease, which ... Californians. Developed as a free download by the ... and QuantiaMD, a company headquartered in Waltham, Massachusetts, the ...
Cached Medicine News:Health News:Media have less than 3 weeks to register for the European Multidisciplinary Cancer Congress 2011 2Health News:Media have less than 3 weeks to register for the European Multidisciplinary Cancer Congress 2011 3Health News:Researchers uncover gene associated with blood cancers 2Health News:Researchers uncover gene associated with blood cancers 3Health News:Cardiac Rehab May Help Heart Patients Live Longer 2Health News:Wayne State researcher developing treatments for Parkinson's with aid of $2.15 million NIH grant 2Health News:Autism Speaks Autism Treatment Network receives $12 million AIR-P grant 2Health News:Interactive mobile app from UCSF and QuantiaMD teaches people how to manage diabetes 2Health News:Interactive mobile app from UCSF and QuantiaMD teaches people how to manage diabetes 3
... Thermovent® T helps provide protection to the exposed ... and extremely lightweight making it ideal for active ... high rate of heat and moisture recovery, it ... ,All HMEs and filters have ISO standard tapered ...
circuitGuard™ Products are available in filter or filter/HME styles., ,High quality air cushion anesthesia masks may be packaged with any circuitGuard™ product....
... Since 1991 Intersurgical Incorporated ... filters, heat and moisture ... therapy products, hand-held nebulizers ... of accessories and connectors ...
... Intersurgical Incorporated manufactures high ... and moisture exchangers, ventilator ... hand-held nebulizers and an ... and connectors for anesthesia ...
Medicine Products: